On July 7, 2021, the U.S. Food and Drug Administration (FDA) issued new warnings regarding hydroxyethyl starch (HES) blood volume expanders. Specifically, the FDA is now requiring manufacturers to ...
Hydroxyethyl starch (HES) products should not be used to treat hypovolemia unless these synthetic colloids are absolutely necessary, warned FDA in a safety communication. The agency is requiring the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback